A newborn giraffe has died in a tragic accident shortly after it was born when it was stepped on by its own mother. The incident occurred at the Nashville Zoo and was announced on Jan. 16 when the zoo’s pregnant giraffe named Nasha went into labor as thousands of people watched the event live online during a live feed. Shortly after labor, however, complications with the baby giraffe began to develop and medical intervention was required from Dr. Matthew DeLisle from the Tennessee Equine Hospital and the zoo’s veterinary team who were able to eventually successfully deliver the calf.
The "Vaccine Vials Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.
Infosys (NYSE: INFY), the global leader in next-generation digital services and consulting, today announced that it has been accredited with the Google Cloud Partner Specialization in the data and analytics space. Infosys achieved this recognition by successfully demonstrating end-to-end capabilities on Google Cloud including data ingestion, streaming, querying, exploration, analysis, storage, and warehousing on cloud. Infosys is among the top global system integrators (SI) to be accredited with this specialization.
Losing yourself in a great novel is one of life’s joys. Here our critics Ceri Radford and Chris Harvey pick the books you need to read
AstraZeneca Plc’s and Daiichi Sankyo Co Ltd.’s drug Enhertu (trastuzumab) has won approval in the US to be used in the treatment of advanced gastric cancer. Specifically, AstraZeneca (AZN) has been okayed by the US Food and Drug Administration (FDA) for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab-based regimen. Following the US approval milestone, AstraZeneca now owes its partner Daiichi $115 million. Sales of Enhertu in the US are recognised by Daiichi. AstraZeneca reports its share of gross profit margin from Enhertusales in the US as collaboration revenue. Gastric cancer is the fifth most common cancer worldwide. In the US, it is estimated that 27,600 new cases of gastric cancer were diagnosed in 2020 and more than 11,000 people died from the disease. The British drugmaker noted that in the US, gastric cancer is most frequently diagnosed in the advanced stage, with only about 5% of patients surviving beyond five years. Approximately one in five gastric cancers are HER2 positive. “Today’s approval of Enhertu represents the first HER2-directed medicine approved in a decade for patients with HER2-positive metastatic gastric cancer,” said AstraZeneca’s Dave Fredrickson. The approval by the FDA was based on positive results from the randomised Phase 2 trial conducted in Japan and South Korea. According to the trial results, Enhertudemonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) and objective response rate (ORR) versus chemotherapy in patients with advanced gastric cancer or GEJ adenocarcinoma who had progressed on at least two or more prior regimens including trastuzumab plus a fluoropyrimidine- and platinum-based chemotherapy combination. “The results from the trial highlight the potential to change clinical practice, showing a 41% improvement in survival and a response rate more than three times higher with Enhertucompared to chemotherapy,” Fredrickson added. This marks the second FDA approval for Enhertu following its approval for use in the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. AZN shares have dropped 16% over the past six months and are up 1.6% over the past year. (See AstraZeneca stock analysis on TipRanks). That’s with a Strong Buy analyst consensus backed by 6 Buy ratings versus only 1 Hold rating. What’s more, the average analyst price target stands at $67.50, which puts the upside potential at a promising 32% in the coming 12 months. Morgan Stanley analyst Mark Purcell last month upgraded AstraZeneca to Buy from Hold and selected it as a preferred large-cap growth stock across the European biopharma sector. One of the reasons cited for the rating upgrade was the strength of the company’s cancer drugs, Calquence and Farxiga. Purcell noted that the company’s oncology pipeline has driven rapid sales growth in the past two years following a number of lean years. The analyst expects AstraZeneca to generate 9% sales growth and 19% EPS growth over the next five years. Meanwhile, the stock scores a Market Neutral 6 on Tipranks’ Smart Score rating, indicating that it is most likely to perform in line with market averages. Related News: Acacia Pops 31% After Cisco Sweetens Buyout Offer To $4.5B Beyond Meat Soars 14% On Taco Bell Partnership Google, Nokia Partner To Develop Cloud-Based 5G Network More recent articles from Smarter Analyst: W.R. Grace Agrees To Discuss 40 North's Improved Buyout Offer; Shares Jump 8% Accenture Buys Wolox To Boost Cloud Business In South America E.W. Scripps Pops 13% After-Market On Billionaire Buffett’s 24.9% Stake GM Partners With Goldman, Mastercard For Credit Card Launch
There's arguably no greater wealth creator on the planet than the stock market. Though other assets have had short periods where they've outperformed, the historical long-term average annual return of 7% for the market, inclusive of dividend reinvestment, is unmatched.
Stomp into the New Year in style with a pair of sturdy shoes designed to tackle rugged terrain
“Sonsational,” a documentary on star South Korean soccer player Son Heung-min, is set to bow on Amazon Prime Video U.K. on Jan. 18. Captain of the South Korea national soccer team, Son also plays for English Premier League club Tottenham Hotspur. The documentary focuses on Son’s life in 2019 and features testimonials by teammates and […]
Maranello (Italy), January 18, 2021 - Ferrari N.V. (“Ferrari”) (NYSE/MTA: RACE) announced today that its financial results for the full year and fourth quarter of 2020 will be released on Tuesday, February 2, 2021. A live audio webcast and conference call of the 2020 full year and fourth quarter results will begin at 2.00 p.m. GMT / 3.00 p.m. CET / 9.00 a.m. EST on Tuesday, February 2. Details for accessing this presentation will be available in the Investors section of Ferrari’s corporate website at http://corporate.ferrari.com prior to the event. Please note that registering in advance is required to access the conference call details. For those unable to participate in the live session, a replay will remain archived on Ferrari’s corporate website (http://corporate.ferrari.com) for two weeks after the call. Attachment FNV 2020 Q4 FY Results Date PR (ENG)
The Scottish fishing industry is protesting Boris Johnson’s Brexit trade deal in Whitehall today. One truck was emblazoned with “Brexit Carnage”, while another said “Incompetent Government Destroying Shellfish Industry”, as they parked up just metres from Downing Street. Others had their business logos proudly displayed amid claims the sector could collapse and that fish prices have plummeted due to the bureaucracy that has left fish rotting at the border.
The "India Primer Market, By Resin Type (Acrylic, Epoxy, Others), By Pack Size (Up to 1 liter, 1 liter, 4-liter, 10 liter and Above), By Price Category (Premium, Mid Range, Economy), By Type, By End Use, By Industry, By Region, Competition, Forecast & Opportunities, 2015-2025" report has been added to ResearchAndMarkets.com's offering.
It's always important to get new symptoms checked out.
More first-time buyers are taking out 35-year mortgages, adding 40% to interest costs on the average deal versus a 25-year loan.
CBBC star's mother, Lucy Lyndhurst, says his death has had a "catastrophic effect" on their family.
‘When it comes to protecting our heritage, due process has been overridden,’ Robert Jenrick says
Dominic Raab has called for the release of Kremlin critic and opposition leader Alexei Navalny after he was detained in Moscow. The Foreign Secretary said on Twitter that Navalny should be “immediately released” after he was detained at a Moscow airport on Sunday after spending five months in Germany recovering from nerve agent poisoning. “Rather than persecuting Mr Navalny, Russia should explain how a chemical weapon came to be used on Russian soil.”
Report Scope: This report provides an overview of the global market for exoskeletons and analyzes market trends. Using 2019 as the base year, the report provides estimated market data for the forecast period 2020 through 2025.New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Exoskeleton Robot: Global Markets" - https://www.reportlinker.com/p06008233/?utm_source=GNW Revenue forecasts for this period are segmented based on mobility, type, power, segment and geography.The report also focuses on the major driving trends and challenges that affect the market and the vendor landscape.The report explains the value chain and current trends in the exoskeleton market.The report includes an impact analysis of the COVID-19 pandemic on the exoskeleton market and includes detailed profiles of the major industry players.The scope of the report includes the global market for commercially deployed exoskeletons. Exoskeletons which are in the pilot phase, are live for demonstration purposes, or are available for rental use or on lease basis have been considered to calculate the overall market size.Report Includes:- An overview of the global market for exoskeleton robot- Estimation of the market size and analyses of market trends, with data from 2019, 2020, estimates for 2021 to 2025 with projections of compound annual growth rates (CAGRs) through 2025- Highlights of quantitative and qualitative data of the exoskeleton robot market by type, mobility, technology, power, industry and region- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, market forecast, and technological advancements within the industry- Description of the impact of the COVID-19 pandemic on the exoskeleton industry- Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies- Company profiles of major players of the industrySummary:Exoskeletons are lightweight, wearable devices designed for rehabilitation, assistance and human-power augmentation.Originally designed for military use, these wearable robotic machines, also known as a robotic suit, powered armor or exosuit, supply part of the power necessary for the activation of energy required for limb movement.Armed forces in the U.S. and other countries have investigated the possible military applications of exoskeletons for more than a decade.Today, the main application of exoskeletons is in healthcare and, to a lesser extent, industrial and commercial settings.They help to improve mobility, enhance force capability and recover motor functions in large joints like the hip and knee.Additionally, they can help to reduce the need for some medications and improve mental health, sleep, pain, posture and balance. Potential exists in the medical market for exoskeletons to provide mobility assistance to the elderly to aid in walking or even climbing stairs.Read the full report: https://www.reportlinker.com/p06008233/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "Computer Accessories - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 6th edition of this report. The 278-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Computer Accessories Market to Reach $19.1 Billion by 2027Amid the COVID-19 crisis, the global market for Computer Accessories estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. External HDDs, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$8.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gaming Accessories segment is readjusted to a revised 5.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.7 Billion, While China is Forecast to Grow at 7.4% CAGRThe Computer Accessories market in the U.S. is estimated at US$3.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.Portable Speakers Segment to Record 4.9% CAGRIn the global Portable Speakers segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.5 Billion by the year 2027, while Latin America will expand at a 5.9% CAGR through the analysis period.Competitors identified in this market include, among others: Hewlett-Packard Development Company LPLexmark International, Inc.LogitechMicrosoft CorporationSeagate Technology LLCSeiko Epson CorporationToshiba CorporationWestern Digital Corporation Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Global Competitor Market SharesComputer Accessories Competitor Market Share Scenario Worldwide (in %): 2019 & 2025Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSISIV. COMPETITION Total Companies Profiled: 38 For more information about this report visit https://www.researchandmarkets.com/r/t5w0w9 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Growth Opportunities in AI, Threat Intelligence and SCA Tools" report has been added to ResearchAndMarkets.com's offering.
(Bloomberg) -- Oil futures held steady, despite a stronger dollar and physical prices in Asia continuing to trade at weaker levels than a month ago.Premiums for Russia’s ESPO have fallen by more than $1 since last month, according to traders who asked not to be identified. It follows a flurry of new Covid cases in China, potentially menacing demand, and flare ups in other regional oil consumers like Japan. Indian energy demand was also off to a shaky start to the year, with sales of transport and cooking fuels dropping from a month earlier.While a second consecutive daily rise in the dollar was adding pressure to prices on Monday, not all data was so downbeat. Chinese refiners processed a record volume of crude in December, the equivalent of about 14 million barrels a day, a sign of just how strongly consumption in the world’s largest crude importer had rebounded into the end of last year. Combined with OPEC+ output cuts and the rollout of Covid vaccines, that had helped push prices to a 10-month high at the start of the year.“The virus will be beaten, and the foundation of economic recovery was laid down in the second half of last year,” said Tamas Varga, an analyst at PVM Oil Associates Ltd. As a result, the pullback in prices “might prove to be short-lived,” he said.Libya’s oil output, meanwhile, has dropped by about 200,000 barrels a day after the closure of a leaking pipeline. The decline underscores how difficult it is for the country to maintain production after almost a decade of civil war.See also: President Biden Won’t Unlock a Wave of Iranian Crude: Julian LeeVolumes of crude stored at sea are also continuing to fall as the market rebalances. Floating storage slipped to 80 million barrels last week, according to Vortexa Ltd, the lowest since April.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.